Clinical Trial Update: SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection [Phase 3]

View source ↗

Summary

Phase 3 SWEET trial comparing once-daily Truvada to twice-daily Combivir for HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 3 | Status: COMPLETED